Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
43,76 The results of the 52-week MAESTRO-NAFLD-1 trial supported the efficacy and safety of resmetirom at doses of 80 mg and 100 mg qd (NCT04197479), which are being applied in the ongoing phase 3 MASH study, MAESTRO-NASH
Understanding the regulatory landscape is an essential component of any protocol design in 2026
Receptor de glucagon: relacionado ao aumento do gasto energtico basal e mobilizao de gordura corporal, sendo o elemento diferencial em relao a terapias que atuam em apenas uma ou duas dessas vias
The beneficial effects of l-carnitine and Infliximab in methotrexate-induced hepatotoxicity: emphasis on Notch1/Hes-1 signaling
Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry
Oral forms must pass through the digestive system, which can lead to variability in absorption, while injectable or IV forms enter the bloodstream directly under medical supervision
US$ 27.42
US$ 27.18
US$ 22.05
